Search For "pharmaceutical"
Covid vaccines create 9 new billionaires: People's Vaccine Alliance
Updated : 4 years, 10 months ago IST
New Delhi [India], May 20 (ANI): At least nine people have become new billionaires since the beginning of Covid pandemic, thanks to the excessive profits pharmaceutical corporations with monopolies on Covid vaccines are making, the People's Vaccine Alliance said on Thursday ahead of a G20 le
Read More
GSK Pharma posts 6 pc growth in Q4 revenue at Rs 807 crore
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 19 (ANI): GlaxoSmithKline (GSK) Pharmaceuticals clocked 6 per cent growth in revenue for the January to March quarter at Rs 807 crore as compared to the same period of the previous fiscal.
Read More
Johnson & Johnson working with Telangana-based pharma company to manuf
Updated : 4 years, 10 months ago IST
New Delhi [India], May 19 (ANI): US pharmaceutical giant Johnson and Johnson has joined hands with Biological E Limited (Telangana-based pharma company) for the manufacturing of the COVID-19 vaccine, as per an official statement on Tuesday.
Read More
DRDO's anti-COVID 2-DG drug an add-on, not substitute for other medicines:
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], May 17 (ANI): The DRDO's new anti-COVID drug 2DG is an add-on and not a substitute for any of the drugs that are used to treat coronavirus patients, said Deepak Sapra, the CEO of Pharmaceutical Services and API, Dr. Reddy's labs.
Read More
COVID-19: Production capacity of Remdesivir increased to nearly 119 lakh v
Updated : 4 years, 10 months ago IST
New Delhi [India], May 17 (ANI): With the sudden increase of cases during the second wave of the pandemic, the government has taken swift actions to enhance the availability of an anti-viral drug Remdesivir across the country. Presently, nearly 119 lakh vials of Remdesivir are being produced
Read More
Lilly signs pact with Natco to accelerate availability of baricitinib for
Updated : 4 years, 10 months ago IST
New Delhi [India], May 17 (ANI): Eli Lilly and Company said on Monday it has issued an additional royalty-free, non-exclusive voluntary license to Natco Pharma, a local pharmaceutical manufacturer of generic medicines.
Read More
Fire breaks out at pharma godown in Indore; medicines related to COVID-19
Updated : 4 years, 10 months ago IST
Indore (Madhya Pradesh) [India], May 17 (ANI): Medicines and medical equipment worth Rs 20-25 lakhs used for the treatment of COVID-19 patients were destroyed in a fire that broke out at a pharmaceutical godown in Indore on Sunday.
Read More
COVID-19: Another 29,021 vials of Remdesivir sent by Gilead Sciences reach
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 15 (ANI): American pharmaceutical company Gilead Sciences sent another 29,021 vials of antiviral drug Remdesivir to India on Saturday in a bid to help the country fight the deadly second wave of COVID-19 pandemic.
Read More
Lupin Q4 PAT up 18 pc at Rs 460 crore on lower input costs
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharma major Lupin Ltd on Thursday reported 18 per cent jump in its consolidated profit after tax to Rs 460 crore.
Read More
Tech transfer, voluntary licenses to improve vaccine supply: FICCI
Updated : 4 years, 10 months ago IST
New Delhi [India], May 13 (ANI): Industry body FICCI said on Thursday the government should focus on connecting with global pharmaceutical companies to facilitate technology transfer and voluntary licenses to Indian companies which have the capacity and capability for mass production of Covi
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 4 years, 10 months ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More
Pharmaceutical market reports strong growth in April: Ind-Ra
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 12 (ANI): India Ratings and Research (Ind-Ra) has said the 51.5 per cent year-on-year growth in India's pharmaceutical market during April was led by a low base effect as the market declined by 10.2 per cent in April 2020 due to Covid-19 lockdown.
Read More